Planning

Microbiology Serology Testing

NHS BLOOD AND TRANSPLANT

This public procurement record has 1 release in its history.

Planning

21 Dec 2021 at 16:03

Summary of the contracting process

The NHS Blood and Transplant (NHSBT) has initiated a procurement process for a tender titled "Microbiology Serology Testing," related to the laboratory services sector. This process is planned and is currently at the planning stage, with an estimated value of £80,000,000. The primary locations for service delivery include Filton and Manchester in the UK. Interested parties should submit expressions of interest by 4:00 PM on 10th January 2022, in order to engage with NHSBT regarding upcoming tender activities.

This opportunity presents a significant avenue for growth for businesses in the diagnostic supplies and laboratory services industries. Companies capable of providing comprehensive microbiology serology solutions, including equipment, software, and ongoing support, will be particularly well-suited to compete. As NHSBT seeks to evaluate market interest and capabilities, suppliers of diagnostic kits, reagents, and automated systems may find this an important opportunity to collaborate on a high-throughput testing solution, positioning their expertise in a crucial healthcare service.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Microbiology Serology Testing

Notice Description

This Prior Information Notice (PIN) follows KEG PIN released on 7th October 2020 reference 2020/S 198-481270 and a further PIN for Microbiology Serology Managed Service Contract released on 28th January 2021 reference 2021/S 000-001795 and all information herein supersedes this.<br/><br/>This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to inform the market of NHSBT's intention to tender, to improve NHSBT's knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available Microbiology Serology Provision and to gauge market interest in the new provision of this service. It is the intention of NHSBT to further engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements.

Lot Information

Lot 1

NHSBT requires a direct contractual relationship with either a manufacturer or any other economic operator for a complete end-to-end integrated solution for the Microbiology Serological screening/testing of blood and non-blood donations , which must include all the necessary equipment, installation, maintenance, consumables, reagents, software including an inter-operability provision with NHSBTs existing IT infrastructure and overall ongoing support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE.

The current contract held with NHSBT for the Microbiology Serology Service includes the supply of the mandatory and selective serology assays, consumables, instrumentation, uninterruptable power supply and software required for result management and interface(s) with host systems; including servers to support the IT infrastructure.

Mandatory testing is undertaken on all blood and non-blood donations. The assays required include: Hepatitis B (HBsAg), Human immunodeficiency virus (HIV 1&2 Ab/Ag), Hepatitis C (anti-HCV), syphilis antibodies, and anti-HBc for non-blood donations. These tests are undertaken on high throughput automated equipment. Additional discretionary testing is also undertaken on select donations. These include testing for human T- lymphotropic virus (anti-HTLV), cytomegalovirus (anti-CMV), malarial antibody (anti-malaria), Hepatitis B antibodies (anti-HBc & anti-HBs) and Trypanosome cruzi (anti-T. cruzi). Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and the assays used in MSL Colindale must be suitable for deceased donor screening.


Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of the contract.

There is a requirement for automated instrumentation to enable high throughput testing of mandatory and discretionary testing for blood and non-blood donors, archiving and long-term storage of plasma samples as part of this contract. Instrumentation for sample sorting is also for consideration.

All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors.

NHSBT undertakes Microbiology Serology testing on approximately 1,700,000 donations per annum across two prinicipal testing sites, namely Manchester and Filton, and also at the Microbiology Services Laboratory at Colindale.

It is NHSBT's intention to engage with the market to understand the market capabilities and interest in tendering for this service. The format for further activities associated with this service will be communicated to those that respond to this PIN.

Expressions of interest should be e-mailed to claire.barnes@nhsbt.nhs.uk by no later than 1600 hours on Monday 10th January 2022. Interested manufacturers and economic operators are requested to provide the following information:

* Company name

* Address

* Contact details

* A brief paragraph to i) summarise your company's information outlining the principal line of business; ii) an explanation of your suitability to provide this service to NHSBT; and iii) confirmation of your interest in participating in the tender.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-030446
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/031951-2021
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

48 - Software package and information systems

71 - Architectural, construction, engineering and inspection services

85 - Health and social work services


CPV Codes

33124130 - Diagnostic supplies

33141625 - Diagnostic kits

33696500 - Laboratory reagents

33698100 - Microbiological cultures

48921000 - Automation system

71900000 - Laboratory services

85111800 - Pathology services

Notice Value(s)

Tender Value
£80,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
21 Dec 20214 years ago
Submission Deadline
Not specified
Future Notice Date
21 Dec 2021Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS16 7FG
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Emersons Green
Westminster Constituency
Filton and Bradley Stoke

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-030446-2021-12-21T16:03:31Z",
    "date": "2021-12-21T16:03:31Z",
    "ocid": "ocds-h6vhtk-030446",
    "initiationType": "tender",
    "tender": {
        "id": "NHSBT1475",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Microbiology Serology Testing",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "71900000",
            "description": "Laboratory services"
        },
        "mainProcurementCategory": "services",
        "description": "This Prior Information Notice (PIN) follows KEG PIN released on 7th October 2020 reference 2020/S 198-481270 and a further PIN for Microbiology Serology Managed Service Contract released on 28th January 2021 reference 2021/S 000-001795 and all information herein supersedes this.<br/><br/>This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to inform the market of NHSBT's intention to tender, to improve NHSBT's knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available Microbiology Serology Provision and to gauge market interest in the new provision of this service. It is the intention of NHSBT to further engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements.",
        "value": {
            "amount": 80000000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "NHSBT requires a direct contractual relationship with either a manufacturer or any other economic operator for a complete end-to-end integrated solution for the Microbiology Serological screening/testing of blood and non-blood donations , which must include all the necessary equipment, installation, maintenance, consumables, reagents, software including an inter-operability provision with NHSBTs existing IT infrastructure and overall ongoing support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) without the need for changes to PULSE. <br/><br/>The current contract held with NHSBT for the Microbiology Serology Service includes the supply of the mandatory and selective serology assays, consumables, instrumentation, uninterruptable power supply and software required for result management and interface(s) with host systems; including servers to support the IT infrastructure.<br/><br/>Mandatory testing is undertaken on all blood and non-blood donations. The assays required include: Hepatitis B (HBsAg), Human immunodeficiency virus (HIV 1&2 Ab/Ag), Hepatitis C (anti-HCV), syphilis antibodies, and anti-HBc for non-blood donations. These tests are undertaken on high throughput automated equipment. Additional discretionary testing is also undertaken on select donations. These include testing for human T- lymphotropic virus (anti-HTLV), cytomegalovirus (anti-CMV), malarial antibody (anti-malaria), Hepatitis B antibodies (anti-HBc & anti-HBs) and Trypanosome cruzi (anti-T. cruzi). Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and the assays used in MSL Colindale must be suitable for deceased donor screening. <br/><br/><br/>Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of the contract. <br/><br/>There is a requirement for automated instrumentation to enable high throughput testing of mandatory and discretionary testing for blood and non-blood donors, archiving and long-term storage of plasma samples as part of this contract. Instrumentation for sample sorting is also for consideration.<br/><br/>All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors.<br/><br/>NHSBT undertakes Microbiology Serology testing on approximately 1,700,000 donations per annum across two prinicipal testing sites, namely Manchester and Filton, and also at the Microbiology Services Laboratory at Colindale.<br/><br/>It is NHSBT's intention to engage with the market to understand the market capabilities and interest in tendering for this service. The format for further activities associated with this service will be communicated to those that respond to this PIN.<br/><br/>Expressions of interest should be e-mailed to claire.barnes@nhsbt.nhs.uk by no later than 1600 hours on Monday 10th January 2022. Interested manufacturers and economic operators are requested to provide the following information: <br/><br/>* Company name <br/><br/>* Address<br/><br/>* Contact details<br/><br/>* A brief paragraph to i) summarise your company's information outlining the principal line of business; ii) an explanation of your suitability to provide this service to NHSBT; and iii) confirmation of your interest in participating in the tender.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33124130",
                        "description": "Diagnostic supplies"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33141625",
                        "description": "Diagnostic kits"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33696500",
                        "description": "Laboratory reagents"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33698100",
                        "description": "Microbiological cultures"
                    },
                    {
                        "scheme": "CPV",
                        "id": "48921000",
                        "description": "Automation system"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85111800",
                        "description": "Pathology services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Filton and Manchester"
                },
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2021-12-21T00:00:00Z",
            "atypicalToolUrl": "http://health.atamis.co.uk"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-13217",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant"
            },
            "address": {
                "streetAddress": "203 Longmead Rd, Avon",
                "locality": "Bristol",
                "region": "UKK12",
                "postalCode": "BS16 7FG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Claire Barnes",
                "email": "claire.barnes@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk",
                "buyerProfile": "https://www.nhsbt.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-13217",
        "name": "NHS Blood and Transplant"
    },
    "language": "en"
}